Windlas Biotech - Quaterly Results - Windlas Biotech Ltd. Latest News

Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.

Received from

Pending at the end of last month

Received

Resolved*

Total Pending #

Pending complaints >3months

Average Resolution time^ (in days)

Directly from Investors

SEBI (SCORES)

Other Sources (if any)

Grand Total

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.

Month

Carried forward from previous month

Received

Resolved*

Pending#

Jun, 2026

Jul, 2026

Aug, 2026

Grand Total

Sr. No.	Fin. Year	Received	Resolved*
1	2021-22	1	1
2	2022-23	1	1
3	2023-24	0	0
4	2024-25	0	0
	Grand Total	2	2

Sr. No.

Fin. Year

Carried forward from previous year

Received

Resolved*

Pending#

2021-22

2022-23

2023-24

2024-25

Grand Total

The revenue zoomed 21.73% to Rs. 1712.85 millions for the quarter ended March 2024 as compared to Rs. 1407.13 millions during the corresponding quarter last year.An average growth of 48.05% was recorded for the quarter ended March 2024 to Rs. 169.49 millions from Rs. 114.48 millions.Operating profit surged to 263.75 millions from the corresponding previous quarter of 187.77 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202403	202303	% Var	202403	202303	% Var	202403	202303	% Var
Sales	1712.85	1407.13	21.73	6309.56	5130.83	22.97	6309.56	5130.83	22.97
Other Income	44.40	23.34	90.23	134.68	99.65	35.15	134.68	99.65	35.15
PBIDT	263.75	187.77	40.46	915.70	702.07	30.43	915.70	702.07	30.43
Interest	2.76	1.64	68.29	11.03	7.86	40.33	11.03	7.86	40.33
PBDT	260.99	186.13	40.22	904.67	694.21	30.32	904.67	694.21	30.32
Depreciation	35.36	35.68	-0.90	134.44	123.64	8.74	134.44	123.64	8.74
PBT	225.63	150.45	49.97	770.23	570.57	34.99	770.23	570.57	34.99
TAX	56.14	35.97	56.07	188.79	144.13	30.99	188.79	144.13	30.99
Deferred Tax	10.93	-6.12	-278.59	15.35	0.63	2336.51	15.35	0.63	2336.51
PAT	169.49	114.48	48.05	581.44	426.44	36.35	581.44	426.44	36.35
Equity	103.99	104.63	-0.61	103.99	104.63	-0.61	103.99	104.63	-0.61
PBIDTM(%)	15.40	13.34	15.39	14.51	13.68	6.06	14.51	13.68	6.06

Company Name	CMP
Sun Pharma. Inds.	1810.00
Dr. Reddys Labs.	1200.10
Cipla	1346.85
Lupin	2029.00
Zydus Lifesciences	1145.25
View more..

Company Name

CMP

1810.00

1200.10

1346.85

2029.00

1145.25

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

^ Average Resolution time is the sum total of time taken to resolve each complaint in days, in the current month divided by total number of complaints resolved in the current month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Windlas Biotech - Quaterly Results